Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity.
about
Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases.Visualization of data in radiotherapy using web services for optimization of workflowRetrospective analysis of stereotactic ablative radiotherapy (SABR) for metastatic lung lesions (MLLs) in comparison with a contemporaneous cohort of primary lung lesions (PLLs)LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspectiveComparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.Hypofractionated radiotherapy for medically inoperable stage I non-small cell lung cancer.Clinical Outcomes of 130 Patients with Primary and Secondary Lung Tumors treated with Cyberknife Robotic Stereotactic Body Radiotherapy.Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models.Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer.Evaluation of ray tracing and Monte Carlo algorithms in dose calculation and clinical outcomes for robotic stereotactic body radiotherapy of lung cancers.Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.DART-bid: dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily: high local control in early stage (I/II) non-small-cell lung cancer.
P2860
Q30570350-2AD48496-F045-4D1B-9BCB-55451ABA3D08Q30885027-99221998-6CB4-4BD5-831E-6E859E5F3395Q33571109-C8250512-6872-4083-A168-12C55BEE594CQ36235727-A0082401-9C36-4521-BC5A-59D8D9AB9D15Q36382039-71FE2870-4854-4C8B-98DC-206A1131A190Q36840379-C8644ED9-3E5D-4F34-AFDF-A69486BC3BE3Q38663392-D39F481E-FEC9-4932-A9F9-FCB2C130B487Q38871523-71DD2127-A2B5-4864-B77F-9E02405153BCQ39015830-516253B1-F884-4A23-9F2E-A649144E2F1CQ43858217-97112F16-0ADA-458E-8766-8D30DFC72730Q47097838-CE9221B6-3351-49C7-82A9-6FCC64DBB435Q53054421-1D851E4C-FAB0-4302-91FF-D7253D8121D4Q53083823-7DAE766C-A417-46D3-85DD-07E40146163D
P2860
Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Stereotactic ablative radiothe ...... able results and low toxicity.
@en
Stereotactic ablative radiothe ...... able results and low toxicity.
@nl
type
label
Stereotactic ablative radiothe ...... able results and low toxicity.
@en
Stereotactic ablative radiothe ...... able results and low toxicity.
@nl
prefLabel
Stereotactic ablative radiothe ...... able results and low toxicity.
@en
Stereotactic ablative radiothe ...... able results and low toxicity.
@nl
P2093
P2860
P1476
Stereotactic ablative radiothe ...... able results and low toxicity.
@en
P2093
C F Waller
F Heinemann
M-B Messmer
N Marschner
V Duncker-Rohr
P2860
P2888
P356
10.1007/S00066-012-0224-Y
P577
2013-01-01T00:00:00Z